Home/ Supplements/ Niacin/ Vanish

Vanish

product on market Capsule PS ProSupps Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 20% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains niacin and calcium, which support metabolic function and bone health. The proprietary matrices for fat burning, euphoria, and appetite control have limited clinical evidence to support their combined efficacy. Overall, research on the specific synergy of these ingredients is minimal.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vanish
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
90
Servings
Other Combinations
Product Type
20%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

25 mg (125% DV)
1.8× RDA — within safe limits 196 studies (A:5, B:63)
Calcium
8 mg (2% DV)
Fat Burning Matrix
251 mg
Euphoric Matrix
66 mg
Appetite Control Matrix
34 mg

Other Ingredients

Hypromellose Silica Magnesium Stearate Maltodextrin Candurin Silver Fine Carmine
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: As a dietary supplement, take 1 capsule per serving. Do not exceed 2 capsules per day. Consult with your physician prior to using this product.

Warnings & Precautions

Synephrine Warning: Do not consume synephrine or caffeine from other sources, including but not limited to, coffee, tea, soda and other dietary supplements or medications containing phenylephrine or caffeine. Contains caffeine. Do not use for more than 8 weeks.

Consult with your physician prior to use if you are pregnant or nursing, or if you are taking medication, including but not limited to MAOI’s, antidepressants, aspirin, non steroidal anti-inflammatory drugs or products containing phylephrine, ephedrine, pseudoephedrine, or other stimulants.

Consult your physician prior to use if you have a medical condition, including but not limited to, heart, liver, kidney, or thyroid disease, psychiatric or epileptic disorders, difficulty urinating, diabetes, high blood pressure, cardiac arrhythmia, recurrent headaches, enlarged prostate or glaucoma. Discontinue 2 weeks prior to surgery or if you experience rapid heart beat, dizziness, severe headache or shortness of breath.

Huperzine Warning: Consult with your physician prior to use if you are pregnant or nursing, have high blood pressure or heart problems, or are taking prescription drugs.

Formulation Notes

Contains caffeine.

Gluten free

Additional Information

Fat metabolizer - Enhances mood and mental clarity - Suppresses appetite and cravings - Promotes fat loss

US

V4

Gluten free

Made in USA

Metadata

Product Details

UPC / SKU6 82055 40987 0
DSLD Entry Date2016-11-21
Product TypeOther Combinations
FormCapsule
DSLD ID67039
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.